Ellington Management Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-8,500
| Closed | -$925K | – | 44 |
|
|
2020
Q1 | $925K | Buy |
+8,500
| New | +$925K | 0.22% | 114 |
|
|
2019
Q2 | – | Sell |
-4,800
| Closed | -$449K | – | 545 |
|
|
2019
Q1 | $449K | Buy |
4,800
+700
| +17% | +$65.5K | 0.08% | 236 |
|
|
2018
Q4 | $299K | Buy |
+4,100
| New | +$299K | 0.09% | 213 |
|
|
2017
Q3 | – | Sell |
-5,900
| Closed | -$471K | – | 604 |
|
|
2017
Q2 | $471K | Buy |
+5,900
| New | +$471K | 0.07% | 252 |
|
|
2014
Q2 | – | Sell |
-9,300
| Closed | -$624K | – | 439 |
|
|
2014
Q1 | $624K | Buy |
+9,300
| New | +$624K | 0.18% | 158 |
|